Osteonecrosis in Primary Antiphospholipid Syndrome is Associated with Previous Glucocorticoid Use and Thrombocytopenia

[1] Sammaritano LR(2020)Antiphospholipid syndrome Best Pract Res Clin Rheumatol 34 101463-736

[2] Xourgia E(2020)Management of non-criteria manifestations in antiphospholipid syndrome Curr Rheumatol Rep 22 51-132

[3] Tektonidou MG(2003)Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging Arthritis Rheum 48 732-1027

[4] Tektonidou MG(2009)Osteonecrosis and antiphospholipid syndrome J Clin Rheumatol 15 130-467

[5] Malagari K(2002)Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum 46 1019-190

[6] Vlachoyiannopoulos PG(2000)Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: Is there a role for antiphospholipid antibodies? Ann Rheum Dis 59 462-306

[7] Kelekis DA(2012)Glucocorticoid-induced osteonecrosis Endocrine 41 183-2108

[8] Moutsopoulos HM(2006)International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 295-271

[9] Rueda JC(2019)Sneddon syndrome: a comprehensive overview J Stroke Cerebrovasc Dis 28 2098-374

[10] Duque MA(2002)Laboratory diagnosis of the antiphospholipid syndrome Thromb Res 108 263-70

[1] Sammaritano LR(2020)Antiphospholipid syndrome Best Pract Res Clin Rheumatol 34 101463-736

[2] Xourgia E(2020)Management of non-criteria manifestations in antiphospholipid syndrome Curr Rheumatol Rep 22 51-132

[3] Tektonidou MG(2003)Asymptomatic avascular necrosis in patients with primary antiphospholipid syndrome in the absence of corticosteroid use: a prospective study by magnetic resonance imaging Arthritis Rheum 48 732-1027

[4] Tektonidou MG(2009)Osteonecrosis and antiphospholipid syndrome J Clin Rheumatol 15 130-467

[5] Malagari K(2002)Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients Arthritis Rheum 46 1019-190

[6] Vlachoyiannopoulos PG(2000)Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: Is there a role for antiphospholipid antibodies? Ann Rheum Dis 59 462-306

[7] Kelekis DA(2012)Glucocorticoid-induced osteonecrosis Endocrine 41 183-2108

[8] Moutsopoulos HM(2006)International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 295-271

[9] Rueda JC(2019)Sneddon syndrome: a comprehensive overview J Stroke Cerebrovasc Dis 28 2098-374

[10] Duque MA(2002)Laboratory diagnosis of the antiphospholipid syndrome Thromb Res 108 263-70